This site uses technical cookies and profiling third party cookies to offer a better user experience; third party cookies require your consent. By continuing to browse the site, clicking or tapping the screen, scrolling the web page or closing this banner, you are agreeing to our use of cookies. For further information or opt out options.
IMA is loading

2018 ISPE Europe Annual Conference • Rome (Italy), 20-21 March 2018

Post published on 14/02/2018

IMA Active at the 2018 ISPE Europe Annual Conference

IMA Active is pleased to take part in the 2018 ISPE Europe Annual Conference, which will be held at the Sheraton Roma Hotel & Conference Center, Rome (Italy), 20-21 March 2018.

The 2018 ISPE Europe Annual Conference will focus on what Industry 4.0 concepts mean in the highly regulated pharmaceutical world. 

Industry 4.0 is becoming a global term. The scope of Industry 4.0 is broad and it could be the next industrial revolution.

With intelligent application of Industry 4.0 concepts into a Pharma 4.0 world, new opportunities to be faster, more agile, and responsive will be addressed. Factories of the future will have to adapt to these concepts in order to stay competitive and survive.

Digitalisation is the trigger to automation and end-to-end integration of computerised systems, and that makes Data Integrity an absolute must in this new world.

Mass serialisation is being implemented in many countries to ensure a constant source in safe and consistent supply chain.

Factories of the Future, Pharma 4.0, Data Integrity, and Mass Serialisation set the scene for the 2018 ISPE Europe Annual Conference. These influences and many more will be examined and discussed at this two-day conference in Rome, Italy.

Conference Highlights

  • 19 March  – Executive Forum:
    Industry 4.0 concepts from other branches will be showcased. What inspires pharmaceutical operations? What does healthcare of the future look like? These burning issues will be presented during our Executive Forum. High-level pharmaceutical executives will provide their perspectives. Insights, from a former EMA member, will highlight the impact that the Brexit will have on the manufacturing environment.
  • 20-21 March  – Keynotes:
    EMA’s update on what is next in regulation and special focus in Annex 1 for aseptic processing will be given.
    Industry’s response is the holistic view on the manufacturing control strategy as a main element of Pharma 4.0. An executive view will highlight the role of leadership and culture during this change. Will it be a revolution or more an evolution?
    For the first time, an ISPE Young Professional from Europe will deliver a keynote.
    Four Tracks: Factories of the Future, Pharma 4.0, Data Integrity, Mass Serialisation.

Discover Agenda»

Get in touch

For any further information, feel free to contact us.